Introduction
Praxelis genus comprises 24 species, however, only two species of this genus have been chemically investigated. Here we investigated Praxelis sanctopaulensis, a native plant from Brazil, that occurs mainly in Cerrado regions.
Objective
The goal was to identify the specialised metabolites from P. sanctopaulensis, and compare with those described from Praxelis and Chromolaena species.
Methods
The phytochemical study of P. sanctopaulensis was performed through different chromatography techniques, including high‐performance liquid chromatography (HPLC), gas chromatography flame ionisation detector (GC‐FID), and ultra‐high‐performance liquid chromatography high‐resolution tandem mass spectrometry (UHPLC‐HRMS/MS). The structures of the compounds were established based on spectroscopic analysis, total correlated spectroscopy (TOCSY), hydrogen decoupling and computational calculations was used to an unequivocal structural elucidation of a new sesquiterpene. The antioxidant activity was evaluated using 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP), and antimicrobial assay was performed by the microdilution method. Comparison of the flavonoids described P. sanctopaulensis was carried out using principal component analysis.
Results
The phytochemical investigation of P. sanctopaulensis led to the isolation of a pair of diastereomers, praxilone A and praxilone B. Seven known compounds were isolated from this species, another 14 fatty acids were detected in hexane fraction, and 26 compounds were identified from ethyl acetate fraction. All these compounds are being described for the first time in this species, with the exception of viridifloric acid. The ethyl acetate fraction showed potent antioxidant activity.
Conclusions
Forty‐seven compounds are described from P. sanctopaulensis. The combination of different techniques of nuclear magnetic resonance (NMR) spectroscopy and computational calculations allowed the unequivocal structure elucidation of a new cadinene. The clustering analysis showed similarities between the flavonoids identified in P. sanctopaulensis and in Chromolaena species.
In this work, the antimicrobial and antioxidant activity of some essential oils (EOs) and their synergistic effects with synthetic preservatives against foodborne pathogenic bacteria were evaluated. Nine EOs were screened against Bacillus cereus, Staphylococcus aureus, Escherichia coli, and Salmonella enterica serotype Typhi, and six of these were associated with methylparaben (MTP) and sodium metabisulfite (MTBS). Essential oils of cinnamon and oregano showed potential antibacterial activity. The combinations of cinnamon + MTP, coriander + MTP, and oregano + MTP, showed synergism against S. enterica ser. Typhi, E. coli, and S. aureus, respectively. Clove oils exhibited higher radical scavenging activity against DPPH. Moreover, clove leaves + MTP presented a synergistic antimicrobial interaction against E. coli and S. enterica ser. Typhi. These findings showed a reduction in the minimal inhibitory concentration (MIC) of the synthetic preservative with a low concentration of EOs, highlighting an alternative source as preservatives in embedded foods and derivatives for the food industry.
Novelty impact statement
The use of essential oils in combination with the synthetic preservative methylparaben (MTP) promoted synergistic antimicrobial effects against foodborne bacteria. The clove leaf oil showed synergism with MTP against Gram‐negative bacteria (FICI = 0.49) and high antioxidant activity (IC50 = 8.06 μg/ml), and this can be used as an alternative source for delaying the oxidative process and for the preservation of food products.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.